Literature DB >> 1969017

Synergistic effect of prostaglandin E1 and isosorbide dinitrate in peripheral vascular disease.

H Sinzinger1, P Fitscha, J O'Grady, F Rauscha, W Rogatti, J R Vane.   

Abstract

Isosorbide dinitrate, which releases nitric oxide in vivo, and prostaglandin E1 synergised in reducing platelet deposition and increasing platelet survival time in patients with peripheral vascular disease.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1969017     DOI： 10.1016/0140-6736(90)90412-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  8 in total

1.  Isosorbide dinitrate inhibits platelet adhesion and aggregation in nonthrombolyzed patients with acute myocardial infarction.

Authors:  J Gebalska; R Wolk; L Ceremuzynski
Journal:  Clin Cardiol       Date:  2000-11       Impact factor: 2.882

Review 2.  Nuclear medicine and atherosclerosis.

Authors:  H Sinzinger; I Virgolini
Journal:  Eur J Nucl Med       Date:  1990

3.  Prostaglandin I2 and the nitric oxide donor molsidomine have synergistic effects on thromboresistance in man.

Authors:  H Sinzinger; F Rauscha; J O'Grady; P Fitscha
Journal:  Br J Clin Pharmacol       Date:  1992-03       Impact factor: 4.335

4.  The effect of endothelium-derived nitric oxide on ex vivo whole blood platelet aggregation in man.

Authors:  P Vallance; N Benjamin; J Collier
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

5.  Interaction of antiplatelet drugs in vitro: aspirin, iloprost, and the nitric oxide donors SIN-1 and sodium nitroprusside.

Authors:  E V Negrescu; B Grünberg; M A Kratzer; R Lorenz; W Siess
Journal:  Cardiovasc Drugs Ther       Date:  1995-08       Impact factor: 3.727

6.  Effect of prostaglandin E2 and 3-morpholinosydnonimine (SIN-1) on arachidonic acid metabolism in fMLP-stimulated rat neutrophils and on thrombin-induced human platelet aggregation.

Authors:  D Pallapies; K U Jirmann; J Rademann; T Simmet; J Rutowski; A Dembińska-Kieć; B A Peskar
Journal:  Agents Actions       Date:  1992-05

7.  Nitric Oxide as a Unique Bioactive Signaling Messenger in Physiology and Pathophysiology.

Authors:  Narendra Tuteja; Mahesh Chandra; Renu Tuteja; Mithilesh K Misra
Journal:  J Biomed Biotechnol       Date:  2004

8.  In Vivo Targeted Metabolomic Profiling of Prostanit, a Novel Anti-PAD NO-Donating Alprostadil-Based Drug.

Authors:  Ksenia M Shestakova; Natalia E Moskaleva; Natalia V Mesonzhnik; Alexey V Kukharenko; Igor V Serkov; Igor I Lyubimov; Elena V Fomina-Ageeva; Vladimir V Bezuglov; Mikhail G Akimov; Svetlana A Appolonova
Journal:  Molecules       Date:  2020-12-13       Impact factor: 4.411
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.